Carregant...
Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
BACKGROUND: One in four cystic fibrosis (CF) patients diagnosed with a pulmonary exacerbation will not recover their baseline lung function despite standard treatment. This highlights the importance of preventing such events. Clinical decision-making can be improved through a simple blood test that...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3930718/ https://ncbi.nlm.nih.gov/pubmed/24586701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0089341 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|